Publicaciones en las que colabora con JUANA MARIA GARCIA PEDRERO (87)

2024

  1. Combined PIK3CA and SOX2 Gene Amplification Predicts Laryngeal Cancer Risk beyond Histopathological Grading

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

  2. Hippo-YAP signaling activation and cross-talk with PI3K in oral cancer: A retrospective cohort study

    Oral Diseases, Vol. 30, Núm. 2, pp. 149-162

  3. Lectin-like Transcript-1 (LLT1) Expression in Oral Squamous Cell Carcinomas: Prognostic Significance and Relationship with the Tumor Immune Microenvironment

    International journal of molecular sciences, Vol. 25, Núm. 8

  4. Low-Level Expression of p-S6 Is Associated with Nodal Metastasis in Patients with Head and Neck Cutaneous Squamous Cell Carcinoma

    International Journal of Molecular Sciences, Vol. 25, Núm. 8

  5. Prognostic value of preoperative inflammatory ratios in early glottic cancer treated with transoral laser surgery

    Head and Neck, Vol. 46, Núm. 4, pp. 819-830

  6. Tumor mutational burden predictability in head and neck squamous cell carcinoma patients treated with immunotherapy: systematic review and meta-analysis

    Journal of translational medicine, Vol. 22, Núm. 1, pp. 135

  7. VAV2 orchestrates the interplay between regenerative proliferation and ribogenesis in both keratinocytes and oral squamous cell carcinoma

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy

    Molecular Cancer, Vol. 22, Núm. 1

  2. Chemo-Immunotherapy: A New Trend in Cancer Treatment

    Cancers, Vol. 15, Núm. 11

  3. Dissecting the functions of cancer-associated fibroblasts to therapeutically target head and neck cancer microenvironment

    Biomedicine and Pharmacotherapy, Vol. 161

  4. Driving role of head and neck cancer cell secretome on the invasion of stromal fibroblasts: Mechanistic insights by phosphoproteomics

    Biomedicine and Pharmacotherapy, Vol. 158

  5. Emerging Role of Decoy Receptor-2 as a Cancer Risk Predictor in Oral Potentially Malignant Disorders

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

  6. Prognostic Significance of β-Catenin in Relation to the Tumor Immune Microenvironment in Oral Cancer

    Biomedicines, Vol. 11, Núm. 10

  7. Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways

    Biomedicine and Pharmacotherapy, Vol. 161

  8. The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinoma

    Nature Communications, Vol. 14, Núm. 1

2022

  1. Tumor-Intrinsic Nuclear β-Catenin Associates with an Immune Ignorance Phenotype and a Poorer Prognosis in Head and Neck Squamous Cell Carcinomas

    International Journal of Molecular Sciences, Vol. 23, Núm. 19

2021

  1. Immune cell infiltrates and neutrophil-to-lymphocyte ratio in relation to response to chemotherapy and prognosis in laryngeal and hypopharyngeal squamous cell carcinomas

    Cancers, Vol. 13, Núm. 9

  2. Ion Channel Dysregulation in Head and Neck Cancers: Perspectives for Clinical Application

    Reviews of physiology, biochemistry and pharmacology, Vol. 181, pp. 375-427

  3. Prognostic relevance of cd4+, cd8+ and foxp3+ tils in oral squamous cell carcinoma and correlations with pd-l1 and cancer stem cell markers

    Biomedicines, Vol. 9, Núm. 6

  4. SDCBP modulates stemness and chemoresistance in head and neck squamous cell carcinoma through src activation

    Cancers, Vol. 13, Núm. 19